21491 ⎘
Preparations for testing; Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier; Organic compounds; Peptides, e.g. proteins the protein being an albumin, e.g. HSA, BSA, ovalbumin
PHYTIC ACID-BASED TERNARY COMPLEX BIOMIMETIC NANOMATERIAL, AND PREPARATION METHOD AND USE THEREOF
#2IRON(III) MACROCYCLIC COMPLEXES WITH MIXED HYROXYL PENDANTS AS MRI CONTRAST AGENTS
#3CONTRAST AGENTS, METHODS FOR PREPARING CONTRAST AGENTS, AND METHODS OF IMAGING
#4COMBINATION THERAPY OF MDNA55 AND A VASCULAR ENDOTHELIAL GROWTH FACTOR A (VEGF-A)
#5TARGETED PROTEIN CONTRAST AGENTS, METHODS OF MAKING, AND USES THEREOF
#6COMPOUNDS FOR USE AS IRON(III) MRI CONTRAST AGENTS
#7Targeted protein contrast agents, methods of making, and uses thereof
#8Contrast agents, methods for preparing contrast agents, and methods of imaging
#9Targeted protein contrast agents, methods of making, and uses thereof
#10METHODS FOR DISTRIBUTING AGENTS TO AREAS OF BRAIN
#11Compounds for use as iron(III) MRI contrast agents
#12Cyanine compounds
#13Targeted protein contrast agents, methods of making, and uses thereof
#14Contrast agents, methods for preparing contrast agents, and methods of imaging
#15CYANINE COMPOUNDS
#16Cyanine compounds
#17Dual mode gadolinium nanoparticle contrast agents
#18Methods and compositions for objectively characterizing medical images
#19Methods for distributing agents to areas of brain
#20Conjugates for medical imaging comprising carrier, targeting moiety and a contrast agent
#21CONTRAST AGENTS, METHODS FOR PREPARING CONTRAST AGENTS, AND METHODS OF IMAGING
#22TUMOR TARGETING PROTEIN CONJUGATE AND A METHOD FOR PREPARING THE SAME
#23Simple method for introducing magnetic particles into a polymer
#24Methods and compositions for diagnosis of iga-and igm-mediated kidney diseases
#25Process for preparing particles of proteinaceous material
#26Conjugated macromolecules
#27Conjugates of macrocyclic metal complexes with biomolecules and their use for the production of agents for NMR diagnosis and radiodiagnosis as well as radiotherapy
#28Macrocyclic metal complexes and their use for the production of conjugates with biomolecules
#29Hydroxypyridinone derivatives, metal complexes thereof and the use thereof for preparing conjugates with biomolecules
#30Conjugates of hydroxypyridinone derivative metal complexes with biomolecules and their use for MRI diagnosis
#31Conjugates for medical imaging comprising carrier, targetting moiety and a contrast agent
#32Method of preselection patients for anti-VEGF, anti-HIF-1 or anti-thioredoxin therapy
#33Methods and compositions for predicting the response to a therapeutic regimen in a subject having a disease associated with cell death